“…The use of multi-locus PCR-RFLP and sequencing of more than two genes produced the discriminatory power necessary to identify CEO-related isolates and differentiate these from non-vaccine-related isolates, particularly in North America, Europe, South America and East Asia (Chang et al, 1997;Han & Kim, 2001;Kirkpatrick et al, 2006b;Ojkic et al, 2006;Oldoni et al, 2008;Neff et al, 2008;Chacon et al, 2010;Moreno et al, 2010). In some cases a combination of PCR-RFLP and sequencing was necessary to achieve a greater degree of discrimination.…”